HYEX
Price
$3.35
Change
-$0.00 (-0.00%)
Updated
May 9 closing price
Capitalization
19.36M
OHCFF
Price
$0.23
Change
-$0.01 (-4.17%)
Updated
May 9 closing price
Capitalization
463.61K
Ad is loading...

HYEX vs OHCFF

Header iconHYEX vs OHCFF Comparison
Open Charts HYEX vs OHCFFBanner chart's image
HEALTHY EXTRACTS
Price$3.35
Change-$0.00 (-0.00%)
Volume$120
Capitalization19.36M
LIGHT AI
Price$0.23
Change-$0.01 (-4.17%)
Volume$25.74K
Capitalization463.61K
HYEX vs OHCFF Comparison Chart
Loading...
View a ticker or compare two or three
VS
HYEX vs. OHCFF commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HYEX is a Hold and OHCFF is a Hold.

Ad is loading...
COMPARISON
Comparison
May 10, 2025
Stock price -- (HYEX: $3.35)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HYEX’s FA Score shows that 0 FA rating(s) are green while.

  • HYEX’s FA Score: 0 green, 5 red.

Price Growth

HYEX (@Pharmaceuticals: Other) experienced а -1.59% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.06%. For the same industry, the average monthly price growth was +12.42%, and the average quarterly price growth was +15.65%.

Reported Earning Dates

HYEX is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.06% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
HYEX($19.4M) has a higher market cap than OHCFF($464K). HYEX YTD gains are higher at: 33.471 vs. OHCFF (25.017). OHCFF has higher annual earnings (EBITDA): -181.76K vs. HYEX (-1.44M). OHCFF has more cash in the bank: 810K vs. HYEX (213K). OHCFF has less debt than HYEX: OHCFF (40K) vs HYEX (1.08M). HYEX has higher revenues than OHCFF: HYEX (2.32M) vs OHCFF (0).
HYEXOHCFFHYEX / OHCFF
Capitalization19.4M464K4,181%
EBITDA-1.44M-181.76K790%
Gain YTD33.47125.017134%
P/E RatioN/A3.23-
Revenue2.32M0-
Total Cash213K810K26%
Total Debt1.08M40K2,710%
FUNDAMENTALS RATINGS
HYEX vs OHCFF: Fundamental Ratings
HYEX
OHCFF
OUTLOOK RATING
1..100
6481
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
41
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9495
PRICE GROWTH RATING
1..100
3546
P/E GROWTH RATING
1..100
4766
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OHCFF's Valuation (41) in the null industry is somewhat better than the same rating for HYEX (76). This means that OHCFF’s stock grew somewhat faster than HYEX’s over the last 12 months.

OHCFF's Profit vs Risk Rating (100) in the null industry is in the same range as HYEX (100). This means that OHCFF’s stock grew similarly to HYEX’s over the last 12 months.

HYEX's SMR Rating (94) in the null industry is in the same range as OHCFF (95). This means that HYEX’s stock grew similarly to OHCFF’s over the last 12 months.

HYEX's Price Growth Rating (35) in the null industry is in the same range as OHCFF (46). This means that HYEX’s stock grew similarly to OHCFF’s over the last 12 months.

HYEX's P/E Growth Rating (47) in the null industry is in the same range as OHCFF (66). This means that HYEX’s stock grew similarly to OHCFF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CGMS26.970.05
+0.19%
Capital Group U.S. Multi-Sector Inc ETF
HMOP38.130.07
+0.18%
Hartford Municipal Opportunities ETF
PFI54.020.01
+0.02%
Invesco Dorsey Wright Financial Momt ETF
SIXL36.56N/A
N/A
ETC 6 Meridian Low Beta Eq Strat ETF
BERZ9.77-0.04
-0.41%
MicroSectors™ St FANG&Inn 3X Inv Ld ETNs

HYEX and

Correlation & Price change

A.I.dvisor tells us that HYEX and HLBBF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HYEX and HLBBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYEX
1D Price
Change %
HYEX100%
N/A
HLBBF - HYEX
23%
Poorly correlated
N/A
INNPF - HYEX
20%
Poorly correlated
+2.83%
OHCFF - HYEX
10%
Poorly correlated
-6.24%
CLCFF - HYEX
3%
Poorly correlated
N/A
UPC - HYEX
2%
Poorly correlated
+2.09%
More

OHCFF and

Correlation & Price change

A.I.dvisor tells us that OHCFF and SWDCF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OHCFF and SWDCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OHCFF
1D Price
Change %
OHCFF100%
-6.24%
SWDCF - OHCFF
22%
Poorly correlated
N/A
HYEX - OHCFF
10%
Poorly correlated
N/A
TKNO - OHCFF
7%
Poorly correlated
+9.26%
GLASF - OHCFF
1%
Poorly correlated
-1.44%
UPC - OHCFF
1%
Poorly correlated
+2.09%
More